← Browse by Condition
Medical Condition

overactive bladder

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for overactive bladder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — overactive bladder Clinical Trials

How many clinical trials are currently recruiting for overactive bladder?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for overactive bladder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for overactive bladder?
overactive bladder research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a overactive bladder clinical trial?
Eligibility criteria for overactive bladder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Valencia Technologies Corporation 1 trial
Walter Reed National Military Medical Center 1 trial
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 1 trial
Axonics, Inc. 1 trial

Recruiting Clinical Trials

NCT05685433
Recruiting

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

Enrollment
200 pts
Location
United States
Sponsor
Valencia Technologies Corporat...
View Trial →
NCT06387329 Phase 4
Recruiting

Bladder Botox UTI Antibiotic Prophylaxis

Enrollment
100 pts
Location
United States
Sponsor
Walter Reed National Military ...
View Trial →
NCT05997992
Recruiting

Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder

Enrollment
100 pts
Location
Taiwan
Sponsor
Taipei Tzu Chi Hospital, Buddh...
View Trial →
NCT06511141
Recruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Enrollment
150 pts
Location
United States
Sponsor
Axonics, Inc.
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology